Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells.

Taura D., Noguchi M., Sone M., Hosoda K., Mori E., Okada Y.

Laboratory Study, published in FEBS Lett (2009) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
FEBS Lett (2009)
Country
England
Reported sample size
—
Source database
PubMed
PMID
19250937
DOI
10.1016/j.febslet.2009.02.031

Abstract (original English)

Induced pluripotent stem (iPS) cells were recently established from human fibroblasts. In the present study we investigated the adipogenic differentiation properties of four human iPS cell lines and compared them with those of two human embryonic stem (ES) cell lines. After 12 days of embryoid body formation and an additional 10 days of differentiation on Poly-l-ornithine and fibronectin- coated dishes with adipogenic differentiation medium, human iPS cells exhibited lipid accumulation and transcription of adipogenesis-related molecules such as C/EBPalpha, PPARgamma2, leptin and aP2. These results demonstrate that human iPS cells have an adipogenic potential comparable to human ES cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipogenesisBiomarkersCCAAT-Enhancer-Binding ProteinsCell Culture TechniquesCell DifferentiationCells, CulturedEmbryonic Stem CellsFatty Acid-Binding ProteinsFibronectins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.